Gardasil Granted Priority Review
Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7
Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7